Open AccessPrognostic Molecular Classification of Appendiceal Mucinous Neoplasms Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Author(s) -
Jing Su,
Guangxu Jin,
Konstantinos I. Votanopoulos,
Lou Craddock,
Perry Shen,
Jeff W. Chou,
Shadi Qasem,
Stacey O’Neill,
Kathleen Perry,
Lance D. Miller,
Edward A. Levine
Publication year - 2020
Publication title -
annals of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.764
H-Index - 173
eISSN - 1534-4681
pISSN - 1068-9265
DOI - 10.1245/s10434-020-08210-5
Subject(s) - medicine , hyperthermic intraperitoneal chemotherapy , cytoreductive surgery , surgical oncology , intraperitoneal chemotherapy , chemotherapy , oncology , surgery , general surgery , cancer , ovarian cancer
Appendiceal mucinous neoplasm (AMN) with peritoneal metastasis is a rare but deadly disease with few prognostic or therapy-predictive biomarkers to guide treatment decisions. Here, we investigated the prognostic and biological attributes of gene expression-based AMN molecular subtypes.